Viewing Study NCT00217568


Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2026-01-27 @ 11:02 AM
Study NCT ID: NCT00217568
Status: COMPLETED
Last Update Posted: 2010-09-21
First Post: 2005-09-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent ovarian epithelial cancer View
None stage III ovarian epithelial cancer View
None stage IV ovarian epithelial cancer View
None peritoneal cavity cancer View